Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4403 publications

The Role of Exenatide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, in Idiopathic Intracranial Hypertension and Polycystic Ovary Syndrome: A Case Report.

The Role of Exenatide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, in Idiopathic Intracranial Hypertension and Polycystic Ovary Syndrome: A Case Report.

Journal: Cureus
Published: October 04, 2025

Erratum for the Research Article "Exendin-4 gene modification and microscaffold encapsulation promote self-persistence and antidiabetic activity of MSCs" by Y. Zhang et al.

Erratum for the Research Article "Exendin-4 gene modification and microscaffold encapsulation promote self-persistence and antidiabetic activity of MSCs" by Y. Zhang et al.

Journal: Science advances
Published: October 03, 2025

Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study.

Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study.

Journal: Nuklearmedizin. Nuclear medicine
Published: September 26, 2025

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals.

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals.

Journal: Nature metabolism
Published: September 25, 2025

Dual-phase exenatide delivery system: PLGA nanoparticles embedded in thermosensitive PLGA-PEG-PLGA hydrogel for sustained glycemic control.

Dual-phase exenatide delivery system: PLGA nanoparticles embedded in thermosensitive PLGA-PEG-PLGA hydrogel for sustained glycemic control.

Journal: Expert opinion on drug delivery
Published: September 22, 2025

Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.

Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.

Journal: JAMA surgery
Published: September 17, 2025

Glucagon-like peptide-1 receptor agonists for the treatment of opioid use disorders: a systematic review.

Glucagon-like peptide-1 receptor agonists for the treatment of opioid use disorders: a systematic review.

Journal: Acta neuropsychiatrica
Published: September 03, 2025

In Silico Exploration of Therapeutics for GLP-1 Receptor Agonist-Induced Nausea and Their in Vivo Validation in Mice.

In Silico Exploration of Therapeutics for GLP-1 Receptor Agonist-Induced Nausea and Their in Vivo Validation in Mice.

Journal: Biological & pharmaceutical bulletin
Published: August 27, 2025

GLP-1R activation restores Gas6-driven efferocytosis in senescent foamy macrophages to promote neural repair.

GLP-1R activation restores Gas6-driven efferocytosis in senescent foamy macrophages to promote neural repair.

Journal: Redox biology
Published: August 19, 2025

Trends in glucagon-like peptide 1 receptor agonist prescribing patterns.

Trends in glucagon-like peptide 1 receptor agonist prescribing patterns.

Journal: The American journal of managed care
Published: August 19, 2025

Corrigendum to "Exendin-4 Attenuates Hepatic Steatosis by Promoting the Autophagy-Lysosomal Pathway".

Corrigendum to "Exendin-4 Attenuates Hepatic Steatosis by Promoting the Autophagy-Lysosomal Pathway".

Journal: BioMed research international
Published: August 11, 2025

The GLP-1 analogue, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice.

The GLP-1 analogue, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice.

Journal: American journal of physiology. Endocrinology and metabolism
Published: August 11, 2025
Showing 1-12 of 4,403

Last Updated: 10/31/2025